Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci
- PMID: 26324294
- DOI: 10.1007/s15010-015-0836-0
Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci
Abstract
Introduction: Enterococci are common causes of infective endocarditis (IE) in both health care and community-based setting. Enterococcal IE requires bactericidal therapy for an optimal outcome. For decades, cell-wall-active antimicrobial agents (penicillins or vancomycin) in combination with aminoglycosides were the cornerstone of the treatment; however, the emergence of antibiotic resistance has significantly reduced the efficacy of these regimens.
Materials and methods: Data for this review were identified by searches of MEDLINE and references from relevant articles on antibiotic combination regimens for the treatment of enterococcal IE. Abstracts presented in scientific conferences were not searched for.
Conclusion: New effective and safe combination treatments, including double-β-lactam and daptomycin/β-lactam combination, are proving useful for the management of IE due to enterococci.
Keywords: Combination antibiotic therapy; Enterococcus spp.; Infective endocarditis.
Similar articles
-
Aminoglycoside resistant enterococcal endocarditis.Infect Dis Clin North Am. 1993 Mar;7(1):117-33. Infect Dis Clin North Am. 1993. PMID: 8463648 Review.
-
Antibiotic treatment of streptococcal and enterococcal endocarditis: an overview.Eur Heart J. 1995 Apr;16 Suppl B:75-9. doi: 10.1093/eurheartj/16.suppl_b.75. Eur Heart J. 1995. PMID: 7671930 Review.
-
Enterococcal endocarditis revisited.Future Microbiol. 2015;10(7):1215-40. doi: 10.2217/fmb.15.46. Epub 2015 Jun 29. Future Microbiol. 2015. PMID: 26118390 Review.
-
Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.Clin Microbiol Infect. 2013 Dec;19(12):1140-7. doi: 10.1111/1469-0691.12166. Epub 2013 Mar 20. Clin Microbiol Infect. 2013. PMID: 23517406
-
Management of infections due to resistant enterococci: a review of therapeutic options.J Antimicrob Chemother. 1997 Aug;40(2):161-70. doi: 10.1093/jac/40.2.161. J Antimicrob Chemother. 1997. PMID: 9301980 Review.
Cited by
-
Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal Resistance.Front Microbiol. 2021 Feb 9;11:605962. doi: 10.3389/fmicb.2020.605962. eCollection 2020. Front Microbiol. 2021. PMID: 33633692 Free PMC article.
-
A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.Sci Rep. 2018 Jan 26;8(1):1632. doi: 10.1038/s41598-018-19986-8. Sci Rep. 2018. PMID: 29374204 Free PMC article.
-
Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting.J Clin Microbiol. 2016 Oct;54(10):2436-47. doi: 10.1128/JCM.00211-16. Epub 2016 May 4. J Clin Microbiol. 2016. PMID: 27147728 Free PMC article. Review.
-
Prevalence of Class 1 Integron and In Vitro Effect of Antibiotic Combinations of Multidrug-Resistant Enterococcus Species Recovered from the Aquatic Environment in the Eastern Cape Province, South Africa.Int J Mol Sci. 2023 Feb 3;24(3):2993. doi: 10.3390/ijms24032993. Int J Mol Sci. 2023. PMID: 36769316 Free PMC article.
-
Infective Endocarditis Due to High-Level Gentamicin-Resistant Enterococcus faecalis Complicated Multisystemic Complications in an Elderly Patient.Infect Drug Resist. 2024 Jun 11;17:2329-2335. doi: 10.2147/IDR.S448612. eCollection 2024. Infect Drug Resist. 2024. PMID: 38882654 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous